APA (7th ed.) Citation

M, B., P, M., P, M., F, V., J, C., JF, T., . . . M, G. (2022). Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ. Journal of medicinal chemistry, 65(19), 13198. https://doi.org/10.1021/acs.jmedchem.2c00998

Chicago Style (17th ed.) Citation

M, Bubenik, et al. "Identification of RP-6685, an Orally Bioavailable Compound That Inhibits the DNA Polymerase Activity of Polθ." Journal of Medicinal Chemistry 65, no. 19 (2022): 13198. https://doi.org/10.1021/acs.jmedchem.2c00998.

MLA (9th ed.) Citation

M, Bubenik, et al. "Identification of RP-6685, an Orally Bioavailable Compound That Inhibits the DNA Polymerase Activity of Polθ." Journal of Medicinal Chemistry, vol. 65, no. 19, 2022, p. 13198, https://doi.org/10.1021/acs.jmedchem.2c00998.